Pfizer (PFE) Receivables - Net (2009 - 2026)
Pfizer (PFE) posted quarterly Receivables - Net of $12.6 billion for Q1 2026, up 6.25% year-over-year from $11.8 billion in Q1 2025, and up 5.99% quarter-over-quarter from $11.9 billion in Q4 2025.
Pfizer (PFE) Receivables - Net (2009 - 2026) Analysis & Trends
Pfizer (PFE) has reported Receivables - Net for 18 consecutive years, with $12.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Receivables - Net rose 6.25% year-over-year to $12.6 billion; the TTM figure through Mar 2026 stood at $12.6 billion (up 6.25% YoY), while the FY2025 annual figure was $11.9 billion, up 3.59% from the prior year.
- Receivables - Net advanced to $12.6 billion in Q1 2026 per PFE's latest filing, from $11.9 billion in the prior quarter.
- Across five years, Receivables - Net topped out at $15.2 billion in Q3 2022 and bottomed at $10.2 billion in Q3 2023.
- Historically, Receivables - Net has averaged $12.3 billion across 5 years, with a median of $11.9 billion in 2025.
- Annual changes were most pronounced in 2022 — Receivables - Net jumped 43.15% — and 2023, when it sank 32.49%.
- Pfizer's Receivables - Net stood at $11.0 billion in 2022, then increased by 5.61% to $11.6 billion in 2023, then retreated by 0.89% to $11.5 billion in 2024, then advanced by 3.59% to $11.9 billion in 2025, then increased by 5.99% to $12.6 billion in 2026.
- Business Quant data shows PFE's Receivables - Net at $12.6 billion in Q1 2026, $11.9 billion in Q4 2025, and $14.3 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 649.90 Bn | 629.14 Bn | 17.26 Bn |
| 2 | AbbVie | 467.27 Bn | 460.70 Bn | 12.70 Bn |
| 3 | Merck | 376.18 Bn | 369.04 Bn | 12.21 Bn |
| 4 | Novartis Ag | 300.31 Bn | 292.62 Bn | 11.24 Bn |
| 5 | Astrazeneca | 256.63 Bn | 251.73 Bn | 12.86 Bn |
| 6 | Amgen | 235.80 Bn | 221.81 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 181.48 Bn | 178.30 Bn | 6.22 Bn |
| 8 | Pfizer | 160.71 Bn | 149.01 Bn | 10.94 Bn |
| 9 | Gsk | 105.41 Bn | 101.24 Bn | 8.24 Bn |
| 10 | Sanofi | 54.87 Bn | 47.49 Bn | 10.79 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 28, 2026 | 12.49 Bn |
| Jun 28, 2026 | 12.49 Bn |
| Mar 29, 2026 | 12.59 Bn |
| Mar 29, 2026 | 12.59 Bn |
| Dec 31, 2025 | 11.87 Bn |
| Dec 31, 2025 | 11.87 Bn |
| Sep 28, 2025 | 14.26 Bn |
| Sep 28, 2025 | 14.26 Bn |
| Jun 29, 2025 | 12.08 Bn |
| Jun 29, 2025 | 12.08 Bn |
| Mar 30, 2025 | 11.85 Bn |
| Mar 30, 2025 | 11.85 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Dec 31, 2024 | 11.46 Bn |
| Sep 29, 2024 | 14.45 Bn |
| Sep 29, 2024 | 14.45 Bn |
| Jun 30, 2024 | 11.39 Bn |
| Jun 30, 2024 | 11.39 Bn |
| Mar 31, 2024 | 10.99 Bn |
| Mar 31, 2024 | 10.99 Bn |